ArticleCancer research2011

Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer.

James L Mohler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.